Amrutanjan Health Care Reports 80% Profit Surge, Sets AGM Date
Amrutanjan Health Care Limited announced Q1 FY2026 results with an 80% increase in profit after tax to ₹831.12 lakhs. Revenue from operations rose 12.3% to ₹9,404.57 lakhs. EPS improved to ₹2.87. OTC Products remained the largest revenue contributor. The company scheduled its 88th AGM for September 23, 2025, set September 16 as the record date, and appointed M/s. SPNP & Associates as Secretarial Auditor for five years.
15May 25
Amrutanjan Health Care Reports Strong Q4 Results, Announces Dividend
Amrutanjan Health Care's Q4 financial results show significant growth. Revenue increased by 6.30% to ₹1.35 billion, while net profit rose by 11.13% to ₹151.80 million. EBITDA improved to ₹177.00 million with a margin of 13.07%. The company also announced a final dividend of ₹2.60 per equity share, reflecting confidence in its financial position and commitment to shareholder value.